Advertisement

Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 630–631 | Cite as

Current Practice and Future Directions for Metaplastic Breast Cancer

  • Waqar HaqueEmail author
  • Bin S. Teh
ASO Author Reflections

Notes

Disclosure

Waqar Haque and Bin S. Teh have no conflict of interest to disclose.

References

  1. 1.
    Tseng WH, Martinez SR. Metaplastic breast cancer: to radiate or not to radiate? Ann Surg Oncol. 2011;18:94–103.CrossRefGoogle Scholar
  2. 2.
    Luini A, Aguilar M, Gatti G, et al. Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature. Breast Cancer Res Treat. 2007;101:349–353.CrossRefGoogle Scholar
  3. 3.
    Haque W, Verma V, Naik N, Butler EB, Teh BS. Metaplastic breast cancer: practice patterns, outcomes, and the role of radiotherapy. Ann Surg Oncol. 2018;25:928–36.CrossRefGoogle Scholar
  4. 4.
    Joneja U, Vranic S, Swensen J, et al. Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1. J Clin Path. 2017;70:255–59.CrossRefGoogle Scholar
  5. 5.
    Adams S. Dramatic response of metaplastic breast cancer to chemo-immunotherapy. NPJ Breast Cancer 2017;3:8.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Department of Radiation OncologyHouston Methodist HospitalHoustonUSA

Personalised recommendations